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1. Introduction 
Several studies have shown that exposure to air pollution leads to important adverse health 
effects resulting in increased morbidity and mortality (Brook, Franklin et al. 2004; Bhatnagar 
2006; Brook, Rajagopalan et al. 2010). According to the World Health Organisation, air 
pollution constitutes the 13th leading cause of mortality in the world (WHO 2009). Increased 
mortality is mostly due to increased cardiovascular diseases in the exposed population, 
particularly those of ischemic nature (Pope, Burnett et al. 2004). While air pollutants are 
composed of a mixture of particulate matter (PM) and gases such as carbon monoxide, 
ozone, sulphur oxide and nitrogen oxide, recent studies have shown that the particulate 
matter component of air pollution is mainly responsible for the cardiovascular health effects 
(Araujo and Nel 2009). This chapter will mostly focus on the links between PM, 
atherosclerosis and ischemic heart disease.  
2. Particulate matter and sources of exposure 
2.1 Classification of particulate matter 
Particulate matter is constituted by compounds of varying sizes, numbers, chemical 
composition, and derived from various sources. They are mainly classified according to 
their size and divided into the following categories: i) Thoracic particles, with an 
aerodynamic diameter less than 10 micrometers (< 10 µm), ii) Coarse particles, with an 
aerodynamic diameter greater than 2.5 micrometers and less than 10 micrometers (PM2.5-10), 
iii) Fine particles, less than 2.5 micrometers and iv) Ultrafine particles (UFP), less than 0.1 
micrometers (<0.1 µm) (Table1) (U.S.EPA 2004).  
2.2 Sources of PM emissions 
The characterization of PM emissions is rather complicated by limitations in the measuring 
instrumentation. In addition, emissions from the same sources change with time and 
operating conditions. What is actually released by the source of the emissions may not be 
what is found in the atmosphere at varying distances from the sources, since particulates 
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undergo a variety of chemical and physical transformations after they have been released 
into the atmosphere (Robinson, Donahue et al. 2007). Particulates are emitted directly from 
various sources such as fossil fuel combustion (primary particles) like diesel and gasoline 
exhaust particles or are formed from gases through chemical reactions involving 
atmospheric oxygen (O2), water vapor (H2O), free radicals such as nitrate (NO3-) and 
hydroxyl (.OH) radicals, reactive species such as ozone (O3), organic gases from 
anthropogenic and natural sources and pollutants such as nitrogen oxides (NOx) and sulfur 
dioxide (SO2) (U.S.EPA 2004). 
As shown in Table 1, various sources are involved in the generation of particles via different 
mechanisms that result in particles with distinct lognormal modes in the particle-size 
distributions by number and volume (nucleation, Aitken, accumulation and coarse modes). 
Nucleation and Aitken modes contain particles derived from the combustion of fossil fuels 
and are due to the nucleation of gas-phase compounds to form condensed-phase species in 
particles that are newly formed with little chance to grow (nucleation mode) or in newly 
formed particles in the process of coagulation (Aitken mode). These modes of generation are 
responsible for the ultrafine particles, emitted indeed from the combustion of fuels such as 
diesel and gasoline used in the operation of motor vehicles, aircrafts and ships. In the 
accumulation mode, particles grow in size and accumulate either by coagulation or by 
condensation, responsible  for the generation of the bigger fine particles that are also emitted 
 
Particles Sources Mode of generation 
Aerodynamic 
diameter (µm) 
Atmospheric 
half-life 
Ultrafine 
particles 
(UFP) 
Combustion of 
fossil fuels 
(gasoline & diesel) 
and emissions from 
mobile sources 
(aircrafts, ships, 
motor vehicles) 
Fresh emissions, 
secondary 
photochemical 
reactions  
(nucleation mode) 
< 0.1 Minutes to 
hours 
Fine particles 
(FP) 
Residential fuel 
combustion, power 
plants, tailpipe and 
brake emissions 
and Oil refineries 
Condensation, 
coagulation 
conversion of gas-to-
particle 
(accumulation mode) 
<2.5 Days to weeks 
Coarse 
particles (CP) 
Suspension from 
construction, plant 
and animal 
fragments, 
disturbed soil 
(mining, farming) 
Evaporation of 
sprays, suspension of 
dusts, mechanical 
disruption  
(crushing, grinding, 
abrasion of surfaces) 
2.5-10 Minutes to 
hours 
Thoracic 
particles (TP) 
- - <10 - 
Source: Modified from Araujo (Araujo and Nel 2009). 
Table 1. Size fractions of PM emissions into the atmosphere. 
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from fuel combustion as well as power plants, oil refineries, tail pipe and brake emissions. 
The coarse mode contains coarse particles (PM 2.5-10) derived from the suspension of material 
from construction, disturbed soil as well as plant and animal fragments. Most of the coarse 
particles in the PM10 are emitted into the atmosphere from the process and open dust 
sources of fugitive emissions. The process sources are associated with industrial operations 
such as rock crushing while the open dust sources are those that produce non-ducted 
emissions of solid particles formed from forces of wind or machinery acting on exposed 
material. The latter include particulate emissions from industrial sources associated with the 
open transport, storage, transfer of raw, intermediate and waste aggregate materials and 
nonindustrial sources such as unpaved roads and parking lots, paved streets and highways, 
agricultural tilling and heavy construction activities (WRAP 2004). Different sources 
involved in the generation of ambient particulate can be classified depending on their 
mobility, into mobile vs. non-mobile sources, as shown in table 2. 
 
Sources 
Percentage contribution  
(% total/ % within category) 
Mobile Sources * 
 
1. On-road Mobile Sources 
       i. Heavy Gasoline Vehicles 
       ii. Light Gasoline Trucks 
       iii. Cars& Motorcycles 
       iv. Diesel Vehicles 
 
2. Non-road Mobile Sources 
       i. Railroads 
       ii. Aircraft 
       iii. Marine 
       iv. Gasoline Equipment 
        v. Diesel Equipment 
28% 
 
           10% 
                   3% 
                   10% 
                   15% 
                    72 % 
 
           18% 
                   7% 
                   7% 
                   10% 
                   20% 
                   56% 
Not Mobile Sources * 72% 
PM 2.5 Emissions by Source Sector ** 
 
Road Dust 
Industrial Processes 
Electricity Generation 
Fires 
Residential Wood combustion 
Waste Disposal 
Non-road Equipment 
Fossil fuel combustion 
On road vehicles 
Solvent Use 
Fertilizer and Livestock 
Miscellaneous 
 
          
          21.5% 
          12.1% 
          11.5% 
          9.2% 
          8.5% 
          6.2% 
          6.0% 
          4.8% 
          3.0% 
          0.2% 
          0.03% 
          17.0% 
* Based on data from the 1999 National Air Quality and Emissions Trends Report (U.S.EPA 1999).  
** Based on data from the 2005 National Summary of Particulate matter emissions by source sector 
(U.S.EPA 2005). 
Table 2. Different sources of PM2.5 emissions into the atmosphere. 
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2.2.1 Mobile sources 
Emissions from mobile sources contribute significantly to measured levels of particulate 
matter. These emissions mainly consist of fine and ultrafine particles. According to the 
report of the 1999 National Emissions by Source in several US states (USEPA 1999), the 
mobile sources include: 1) On-road sources, which account for ~ 10% of the total emissions 
in US and include emissions from Cars and Motorcycles (15%), Diesel vehicles (72%), Light 
Gasoline Trucks (10%) and Heavy Gasoline Vehicles (3%), 2) Non-road sources, which 
accounts for 18% of total emissions in US including emissions from Marine (10%), Diesel 
(56%) and Gasoline Equipment (20%) (Table 2). Indeed, emissions from diesel vehicles 
accounted for about three-quarter of the on-road emissions (USEPA 1999). Importantly, 
particles derived from motor vehicles seem to be especially potent in increasing 
cardiovascular mortality (Laden, Neas et al. 2000; Pekkanen, Peters et al. 2002) and cardiac 
hospital admissions (Janssen NA 2002). 
2.2.2 Non-mobile sources 
Emissions from Non-mobile sources, also known as the Point Sources, contribute in a larger 
degree to the total PM emitted into the atmosphere throughout the US (Table 2) (USEPA 
1999). Point sources are stationary, large and identifiable sources of emissions that release 
pollutants into the atmosphere. According to the National Emissions statistics of PM2.5 
throughout the US in 1999, non-mobile sources include large industries such as 
manufacturing plants, power plants, fires, residential wood combustion, waste disposal, non 
road equipment, paper mills and refineries (table 2) (USEPA 1999). Additional sources 
include biogenic non-anthropogenic sources such as trees and vegetation, oil and gas seeps 
and microbial activity (USEPA 1999). 
3. Particulate matter, duration of exposure and cardiovascular health  
effects 
Exposure to air pollutants has been associated with increased risk for adverse 
cardiovascular health effects, mostly attributed to those in the particulate phase. Indeed, 
ambient particulate matter (PM) has been linked to a whole variety of atherothrombotic 
endpoints (Ghio, Hall et al. 2003; Pope, Muhlestein et al. 2006; Baccarelli, Martinelli et al. 
2009). Although epidemiological studies with PM10 and PM2.5 show that exposure to these 
particles are associated with adverse cardiovascular effects such as myocardial infarction 
and stroke death, greater effects are associated with the smaller particle sizes (PM 2.5) 
(Analitis, Katsouyanni et al. 2006; Pope 2006; Zanobetti and Schwartz 2009). Thus, the risk 
of cardiovascular mortality posed by PM10 exposure could be in a good degree due to its 
fraction of particles < 2.5 µm in diameter (PM2.5). According to the World Health 
Organization, exposure to PM may be responsible for an estimate of about 800,000 excess 
deaths worldwide in each year as a result of myocardial infarction, arrhythmias or heart 
failure (WHO 2002). Several epidemiological studies have shown that the increased risk in 
cardiovascular morbidity and mortality occurs as a result of both short- and long-term 
exposures to PM as summarized in Table 3. 
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Duration 
of 
exposure 
Type of 
Study 
Study  
No. of 
subjects 
Exposure 
variable  
Outcome 
variable  
Major Findings  Ref. 
Short-
term 
exposure 
studies 
Time Series  
NMMAPS 
~50 
million 
PM10 
Daily CP 
mortality 
20 µg/m3 increases in 
PM 10 caused 0.6% 
increased in daily CP 
mortality in adults 
from 20 to 100 US 
cities and hundreds of 
countries. 
(Dominici, 
Zeger et al. 
2000; 
Dominici, 
McDermott 
et al. 2003; 
Peng, 
Dominici et 
al. 2005; 
Dominici, 
Peng et al. 
2007) 
NCHS 
NCHS 
data on 
112 US 
cities 
PM2.5 
Daily CV 
mortality 
10 µg/m3 increase in 
2-day averaged PM 2.5 
caused 0.98% and 
0.85% increase in 
daily all cause and CV 
mortality respectively 
(Baccarelli, 
Martinelli et 
al. 2009) 
APHEA2 
~43 
million 
PM10 
Daily CV 
mortality 
20 µg/m3 increases in 
PM 10 caused a 1.5% 
increased in daily CV 
mortality in adults 
from 29 European 
cities. 
(Katsouyanni 
2003; 
Analitis, 
Katsouyanni 
et al. 2006) 
APHENA 
NMMAPS, 
APHEA2 
& 
Canadian 
studies 
PM10 
Daily CV 
mortality 
10 µg/m3 increase in 
PM 10 caused 0.2 to 
0.6% increased in 
daily all-cause 
mortality in 
individuals from the 
US (90 cities), Europe 
(22 cities) and Canada 
(12 cities), mostly in 
individuals>75-year 
old. 
(Samoli, 
Peng et al. 
2008) 
Case cross-
over  
IHCS  ~12865 PM2.5 
Ischemic 
coronary 
events 
10 µg/m3 increases in 
PM2.5 caused a 4.5% 
increase in daily acute 
ischemic coronary 
events in patients in 
UTAH. Patients with 
pre- existing CAD 
have significant 
increased frequency. 
(Pope, 
Muhlestein 
et al. 2006) 
MI 
Registry in 
Augsburg 
(data from 
KORA) 
691 Traffic  MI 
Exposure to traffic for 
1 h increases the 
relative risk for an MI 
by 2.92 before the 
event. 
(Peters, von 
Klot et al. 
2004) 
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Duration 
of 
exposure 
Type of 
Study 
Study  
No. of 
subjects 
Exposure 
variable  
Outcome 
variable  
Major Findings  Ref. 
Long-
term 
exposure 
studies 
Prospective 
Cohort 
American 
Cancer 
Society II 
(extended 
analysis) 
~500000 PM2.5 
CV 
mortality 
10 µg/m3 increase 
long-term exposure to 
PM 2.5 in a 16-year 
study caused 12% 
increased in risk for 
CV death. The largest 
cause of mortality was 
due to Ischemic heart 
disease and smaller 
numbers of people 
died from 
arrhythmias and heart 
failure 
(Pope, 
Burnett et al. 
2004) 
 
Harvard 
Six Cities 
(extended 
analysis) 
8096 PM2.5 
CV 
mortality 
10 µg/m3 increase 
long-term exposure to 
PM 2.5 in a 28-year 
study of six US cities 
residents show a 
1.28% increased in 
relative risk for CV. 
Significant reduction 
in CV mortality was 
observed in some 
cities and this 
correlate with 
decrease in PM 2.5 
(Laden, 
Schwartz et 
al. 2006) 
 NHS 66250 PM10 
Acute 
events of 
CV and 
CV 
mortality 
10 µg/m3 increase in 
long-term exposure to 
PM 10 caused a 43% 
increased in fatal CAD 
disease among nurses 
from northeastern US 
(Puett, 
Schwartz et 
al. 2008) 
 
Woman’s 
Health 
Initiative 
65893 PM2.5 
CV acute 
events 
and CV 
mortality 
10 µg/m3 increases in 
long-term exposure to 
PM 2.5 caused a 24% 
and 76% increase in 
CV acute events and 
CV mortality 
respectively in healthy 
post-menopausal 
women in 36 US cities. 
(Miller, 
Siscovick et 
al. 2007) 
NMMAPS, National Morbidity, Mortality and Air Pollution Study; APHEA2, Air Pollution and Health: 
A European Approach; IHCS, Intermountain Heart Collaborative Study; APHENA, Air Pollution and 
Health: A Combined European and North American Approach study; CV, Cardiovascular; CP, 
Cardiopulmonary; MI, Myocardial Infarction; KORA, Cooperative Health Research in the Region of 
Augsburg; NCHS, National Center for Health Statistics. Modified from (Araujo and Brook 2011) 
Table 3. Selected studies showing a relationship between exposure to PM of different 
lengths of duration and increased cardiovascular morbidity and/or mortality. 
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3.1 Short-term exposures 
Although the mechanisms involved in the generation of PM-mediated adverse 
cardiovascular health effects are still not clear, several studies have shown that short-term 
exposures to PM results in cardiovascular systemic effects (Table 3). Thus, in a study 
carried out in eight European cities, zero to one-day exposure to PM10 and black smoke 
associated with a significant increase in cardiac hospital admission in subjects of all ages 
and ischemic heart disease in people over 65 years (Le Tertre, Medina et al. 2002). Results 
from the National Morbidity, Mortality, and Air Pollution study (NMMAPS) and the Air 
Pollution and Health: A European Approach (APHEA2) involving ~50 and ~43 million 
subjects respectively found that there was 0.6 and 1.5 % increase in daily 
cardiopulmonary mortality rate for every 20 µg/m3 increase in PM10, respectively 
(Dominici, McDermott et al. 2003; Analitis, Katsouyanni et al. 2006). Several studies have 
also shown that exposure to PM2.5 result in similar or even larger magnitudes of 
association. For instance, in the Intermountain Heart Collaborative Study (IHCS) 
involving 12,865 subjects, 10 µg/m3 increases in ambient PM 2.5 associated with a daily 
increase of 4.5% in acute ischemic coronary events. Studies have also shown that short-
term exposures to PM associated with increased risk for hospitalization for cardiovascular 
diseases. Dominici et al showed among 11.5 million U.S medicare enrollees > 65 year old 
that admission rates for all cardiovascular causes increased in association with 10 µg/m3 
increases in PM2.5, leading to an increase of 0.44% in ischemic heart, 1.28% in heart failure 
and 0.81% in cerebrovascular diseases (Dominici, McDermott et al. 2003). There is also 
evidence that exposure to UFP associates with increased risk for cardiac hospital 
admissions, as discussed in section 6. 
3.2 Long-term exposures 
A number of studies have also shown an association between long-term exposures to PM 
and cardiovascular morbidity and mortality (Table 3). Thus, in an extended analysis (16-
year follow-up) of a cohort survival study from the American Cancer Society, 10 µg/m3 
increases in long-term exposure to PM 2.5 associated with a 12% increase in CV deaths, most 
of which was due to ischemic heart disease, with a smaller percentage due to arrhythmias 
and heart failure (Table 3) (Pope, Hansen et al. 2004). This study suggests that long-term PM 
exposures carry greater cardiovascular risk as compared with the magnitude of risk 
observed in studies evaluating short-term exposures. An even stronger correlation was 
observed in the Women Health Initiative Study involving 65,893 post menopausal women, 
which showed 24% and 76% increase in cardiovacular acute events and mortality, 
respectively (Miller, Siscovick et al. 2007).  
4. Particulate matter and cardiovascular ischemic effects 
It is noteworthy that PM-mediated enhancement of cardiovascular morbidity and mortality 
is mostly due to the promotion of ischemic events, such as myocardial infarction. The fact 
that PM exposures associate with cardiovascular ischemic endpoints both in the short-term 
as well as long-term exposure studies suggests that PM activates various pathways resulting 
in both short- as well as long-term effects.  
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Indeed, several studies have shown that short-term (hours to days) exposures to PM 
significantly enhance cardiovascular risk (Peters, Frohlich et al. 2001; Miller, Siscovick et al. 
2007). Although the mechanisms by which exposure to PM induces cardiac ischemic events 
such as myocardial infarctions are not yet well defined, several studies have suggested that 
PM can be associated with hemodynamic, hemostatic as well as cardiac rhythm alterations 
that may account for some of the PM-induced acute cardiac events. In support of this 
observation, there are significant associations between exposure to ambient PM and 
acceleration of heart rate, diminished heart rate variability (Pope and Kalkstein 1996; Peters, 
Doring et al. 1997), ventricular fibrillation, increased number of therapeutic intervention in 
patients with implanted cardiovascular-defibrillators (Peters, Liu et al. 2000) and increased 
plasma viscosity (Peters, Doring et al. 1997).  
Many studies have also reported a strong correlation between long-term exposure to PM 2.5 
and cardiac ischemic endpoints as shown above, which strongly suggests that PM-
enhancement of atherosclerosis could be one of the pathogenic mechanism(s). Indeed, 
several studies involving human subjects have shown significant associations between PM2.5 
exposure and atherosclerosis. Thus, in a cross-sectional study carried out in 798 individuals 
in Los Angeles by Kunzli et al, carotid intima-medial thickness (CIMT) was found to 
increase by 5.9% for every 10 µg/m3 rise in PM2.5 levels (Kunzli, Jerrett et al. 2005). Same 
group found an acceleration in the annual rate progression of CIMT among individual 
living within 100 m of a highway which was more than twice the population mean 
progression (Kunzli, Jerrett et al. 2010). In another study, Hoffman et al found an association 
between coronary artery calcification (CAC) scores, an index of coronary atherosclerosis, 
and long-term residential exposure to high traffic (Hoffmann, Moebus et al. 2007). They 
found that in 4,494 participants, subjects living within 101-200 m, 51-100 or less than 50 m 
from a major road showed 8%, 34% and 63% increase respectively in the probability of 
having CAC compared with subjects living >200 m. Furthermore, Diez Roux et al reported a 
1-3% increase in CIMT per 21 µg/m3 increase in PM10 or 12.5 µg/m3 increase in PM2.5 in 
subjects exposed to PM10 over long-term (20-year means and 2001 mean) and 20-year PM2.5 
respectively (Diez Roux, Auchincloss et al. 2008). Likewise, in a related study, Allen et al 
reported an increase risk for aortic calcification with PM2.5 exposure (Allen, Criqui et al. 
2009). All these studies confirm that exposure to PM triggers-off the development of 
atherosclerosis in humans, which may be a major mechanism how long-term exposure to 
PM leads to enhanced cardiovascular ischemic endpoints.  
Three putative ”general mediating” pathways (Fig.1) have been proposed for the 
cardiovascular effects of air pollutants such as: 1) Autonomic nervous system imbalance, 2) 
Induction of pumonary and thereby systemic inflammation/oxidative stress via ”spill-over” 
of mediators (e.g. cytokines, activated white cells/platelets) into the systemic circulation, 3) 
Access of particles or specific chemical constituents into the systemic circulation which 
thereby cause direct affects upon the heart and vasculature (Araujo and Brook 2011) (Fig.1). 
Some of the PM-mediated short-term effects may be related to pathway #1. On the other 
hand, the occurrance of long-term effects strongly suggests that PM would promote 
atherosclerosis, likely via a combination of pathway #2 and #3. However, while it has been 
proposed that UFP could access the systemic circulation (pathway #3), clear confirmation of 
this possibility is still lacking. 
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?
?
 
 
 
Fig. 1. Possible mechanisms that link exposure to PM with cardiovascular diseases. Three 
mediating pathways are proposed. Air pollution can; 1) Activate the autonomic nervous 
system resulting in the alteration of heart rate viability and induction of dysrhythmias, 2) 
Enhance atherothrombotic processes that can lead to development of pulmonary oxidative 
stress and inflammation with systemic “spill-over” of inflammatory mediators, 3) Particles 
and/or their chemical constituents can translocate directly to the systemic circulation. CHF= 
Congestive heart failure, CVA= Cerebrovascular accident, PVD= Peripheral vascular 
disease, EC= Endothelial cells, IHD= Ischemic heart disease. Taken from (Araujo and Brook 
2011). 
It is possible then that the predominant mechanism(s) mediating PM-enhancement of 
cardiovascular ischemic events could be different among studies that evaluate short- vs. 
long-term effects. In addition, particulate of different size fractions as well as originating 
from different sources could exhibit significant differences in their ability to induce systemic 
vascular effects as will be discussed in the next two sections below. 
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5. What determines PM-related cardiovascular toxicity? 
5.1 Particle size 
The ability of PM to induce adverse health effects in humans may be a function of a number 
of factors, some of which are likely to determine its deposition in the respiratory tract and 
ability to induce both local pulmonary as well as systemic vascular effects. These factors 
include, among others, size, shape, composition and density of ambient particles  
Particle size appears to be an important determinant of PM toxicity. For instance, while 
PM10 has been associated with ischemic cardiovascular events, there is increasing evidence 
that smaller particles may be responsible for most of cardiovascular adverse health effects. 
Thus, PM2.5 and UFP are thought to be more toxic than larger particles, which may be partly 
based on their ability to access deeper portions into the lungs. These particles can pass the 
proximal airway of the respiratory system (throat and larynx) and get deposited into the 
tracheobronchial airway of the lungs or in the gas exchange region (alveolar ducts or alveoli 
of the lungs)(Oberdorster, Oberdorster et al. 2005). However, as population studies have 
shown that the strengths of association of PM with cardiovascular effects are larger with 
PM2.5 than with PM10, which is in support of the notion that a small particle size would 
facilitate cardiovascular toxicity, there is still a paucity of epidemiological studies in relation 
to the cardiovascular effects of UFP.  
5.2 Importance of chemical composition and redox potential 
Particles of different sizes have different chemical composition and redox potential that may 
affect their ability to act through the various pathways. It appears that PM ability to trigger 
and/or enhance reactive oxygen species (ROS) production, resulting in tissue oxidative 
stress, may be of key importance in cardiovascular tissues. For instance, PM-mediated ROS 
formation may be central in the enhancement of atherosclerosis by PM, likely due to the 
promotion of systemic prooxidant and proinflammatory effects. Since atherosclerosis is 
characterized by lipid deposition and oxidation in the arterial wall, factors that promote 
lipid oxidation and retention in the artery wall may exacerbate the pathogenic process. 
These lipids are derived from plasma low-density lipoprotein (LDL) particles that travel 
into the arterial wall and get trapped in the subendothelial space where they can be 
oxidatively modified (Steinberg 1997; Araujo, Barajas et al. 2008). Several studies using 
different PM size fractions (PM10, PM2.5, UFP) to expose different animal models (apoE-/- 
mice, LDL-R-/- mice and hyperlipidemic rabbits) via different modes of exposure 
(inhalation of CAPs, oropharyngeal/intratracheal instillation) converge to demonstrate 
that PM exposure leads to enhanced atherosclerotic lesions or plaques with altered 
composition, suggesting that the associations encountered in epidemiological studies are 
very likely to be causal (Araujo 2011a). 
Experimental animal data also supports the notion that particulate of the smallest size may 
be able to induce larger proatherogenic effects. Araujo et al reported that exposure of apoE-/- 
mice to concentrated ambient particles (CAPs) in the fine and ultrafine-size ranges resulted 
in a significant increase of lipid peroxidation in the liver and triggering of a Nrf2-regulated 
antioxidant response in mice exposed to ultrafine particulate, likely to be indicative of the 
greater levels of oxidation induced by ultrafines. Stronger prooxidant effects led to bigger 
atherosclerotic plaques in mice exposed to ultrafines (Araujo, Barajas et al. 2008). The greater 
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toxicity of UFP could be due to their greater content in prooxidant organic chemicals, 
greater bioavailability for those reactive compounds due to their larger surface-to-mass ratio 
and/or greater lung retention (Araujo and Nel 2009). Indeed, UFPs contained twice as much 
organic carbon (OC) as FP did, accompanied by an increase in the relative content of 
polyaromatic hydrocarbon (PAH), which may have been one of the factors why UFP 
induced greater enhancement of aortic atherosclerosis than PM2.5 did (Araujo, Barajas et al. 
2008). In addition, transition metals have also been largely implicated in the PM hazardous 
health effects (Ntziachristos, Froines et al. 2007; Ayres, Borm et al. 2008). While there is a 
large experimental evidence that points out towards these various candidates, there is no 
substantial evidence that links PAH contents with adverse cardiovascular effects as of yet.  
5.3 Factors determining susceptibility 
PM cardiovascular toxicity could also be influenced by different susceptibility to PM-
mediated systemic effects. Indeed, epidemiological, toxicological and controlled human 
exposure studies have examined whether the health effects of PM are modulated by 
preexisting conditions such as coronary artery disease, congestive heart failure, obesity, age 
and diabetes among others. Several reports identify obesity as a likely susceptibility factor. 
For instance, short-term exposure to PM has been shown to associate with a reduction in 
heart rate variability (Schwartz, Litonjua et al. 2005) and higher levels of plasma 
inflammatory markers such as IL-6 and C-reactive protein in a greater degree among obese 
individuals (Dubowsky, Suh et al. 2006). Studies of the Veteran’s Normative Aging and 
Women’s Health Initiative Cohorts also show that long-term exposure to PM associated 
with an increase in inflammatory markers and cardiovascular events in individuals with 
body mass index (BMI) ≥ 25 kg/m2 compared with < 25 kg/m2 (Zeka, Sullivan et al. 2006; 
Miller, Siscovick et al. 2007). In addition, it appears that preexistent congestive heart failure 
increases the susceptibility to PM-induced cardiovacular events and mortality (Bateson and 
Schwartz 2004; Pope 2006). Additional studies are required to confirm these findings and 
better dissect potential susceptibility factors. 
6. Relationship between sources of emission and cardiovascular health 
effects  
While different sources of emission may generate pollutants with different physicochemical 
characteristics, the mechanisms involved in PM-mediated enhancement of cardiovascular 
morbidity and mortality have been assumed to be common to all particulate derived from 
various sources (Figure 1). However, this may be an oversimplification of a rather complex 
relationship that has not been well studied yet, partly due to the lack of understanding 
about the critical toxic components of air pollution that are responsible for the 
cardiovascular effects. 
PM from different sources may trigger and/or enhance ROS formation which may lead to 
tissue oxidative stress, inflammation, endothelial dysfunction, resulting in the formation of 
atherosclerotic plaques (Figure 2). The particular source of emission is to play an important 
role in determining particle size and chemical composition. It should also be noted that 
some elements in PM are more source-specific than others and therefore, the extent of PM 
induction of cardiovascular effects may largely depend on the specific source of PM. For 
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instance, elements such as iron and zinc are mostly derived from steel production while 
nickel is linked to oil combustion (Li Z 2004; Zheng L 2004; Qin Y 2006). Some elements 
might be site-specific. For instance, coal and oil combustion at power plants are the main 
source of sulphur in Canada. Therefore, better understanding of the sources and type of 
emissions may help to elucidate the particle components responsible for cardiovascular 
toxic effects. 
 
Fig. 2. Mechanisms involved in the development of ischemic heart disease generated 
from PM emitted from different sources. PM, emitted from different sources, may induce 
various systemic effects and modulate various pathways resulting in enhanced ischemic 
heart disease events. 
One clear example about the difficulties to study the influence of the source of exposures on 
health effects is in relation to the particle size. Numerous studies have shown that 
combustion-derived particles from mobile sources are associated with increased 
cardiovascular morbidity and mortality. Studies have shown that PM2.5 exhibits a larger 
association with cardiovascular endpoints than PM10. These associations have been 
established mostly using metrics based on PM mass. However, there has been a notion that 
even smaller particles such as ultrafines would be more active to induce cardiovascular 
effects based on experimental in-vitro and animal evidence (Schulz, Harder et al. 2005; 
Araujo, Barajas et al. 2008) but supportive epidemiological evidence is somewhat weaker. 
Exposure to UFP comes from both mobile as well as non-mobile sources but capturing their 
toxicity is rather difficult since they are very dependant on the proximity to the source and 
the conventional particle mass or particle number-based metrics are inadequate to fully 
capture their toxic potential. Therefore, dissecting the actual contribution of the source of 
PM to cardiovascular events is difficult as no adequate parameters have so far been used to 
assess the contribution of UFP at the point of exposure in relation to the point of emission. 
Despite the short-comings related to the use of total particle number concentration to 
estimate UFP concentration, studies have shown that exposure to UFP significantly 
associates with increased hospital admissions due to acute myocardial infarction (Lanki, 
Pekkanen et al. 2006; von Klot, Peters et al. 2005) as well as heart failure (Belleudi, Faustini et 
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al.; Dominguez-Rodriguez, Abreu-Afonso et al. 2011 et al.), summarized in table 4. 
Unfortunately, UFP assessment was only made based on particle number concentration 
whereas a more comprehensive characterization of the UFP and the particular source of 
emissions would have been very informative. 
 
 
Study 
Number of 
cardiac 
hospital 
admissions 
Environmental exposure 
parameters 
Types of 
cardiac 
admissions 
Mayor findings 
(von Klot, 
Peters  
et al. 2005) 
6655 first  
hospital 
readmissions 
PNC 
PM10 
Gases (CO, NO2, O3) 
Acute MI 
Angina 
pectoris, HF 
Dysrhythmia 
Cardiac 
readmissions 
increased by 2.1% 
and 2.6% per each 
increase of 10 µg/m3 
of PM10 and 10 000 
particles/cm3, 
respectively 
(Lanki, 
Pekkanen 
 et al. 2006) 
26 854 first MI 
admissions 
PNC 
PM10 
Gases (CO, NO2, O3) 
Acute MI Hospitalization for 
first MI increased by 
0.5% per each 
increase of 10 000 
particles/cm3 (lag 0). 
Associations were 
greater among fatal 
events and subjects 
< 75 years 
(Belleudi, 
Faustini  
et al. 2010) 
90 056 cardiac 
hospital 
admissions 
PNC 
PM10 
PM2.5 
HF 
ACS 
Other cardiac 
causes 
HF and ACS 
increased by 2.4% 
and 2.3% 
respectively per each 
increase of 10 µg/m3 
of PM2.5 (lag 0). HF 
increased by 1.7% 
per each increase of 
9392 particles/cm3 
(lag 0) 
(Dominguez-
Rodriguez, 
Abreu-
Afonso  
et al. 2011) 
3229 hospital 
admissions 
PNC 
PM10 
PM2.5 
PM1 
Gases (CO, SO2, NO2, O2) 
HF 
ACS 
UFP found to be a 
risk factor for HF 
admissions 
compared to 
admissions for ACS 
(odds ratio = 1.4) 
ACS, acute coronary syndromes; HF, heart failure; MI, myocardial infarction; PM, particulate matter; 
PNC, particle number concentration; UFP, ultrafine particles. Modified from (Araujo 2011b). 
Table 4. Studies linking exposure to ultrafine particles and cardiac hospital admissions. 
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The assessment of Nickel content exemplifies another situation where a thorough 
characterization of the source of emissions might prove to be helpful. Nickel (Ni) is an 
important metal produced from the combustion of fossil fuels. Ni content in PM2.5 has been 
identified as an indicator of oil combustion not only from mobile sources such as vehicles 
(Brook2004) and ships (Ying, Yue et al. 2009) but also from industries such as cement 
production, asbestos mining and milling, iron and steel foundries, municipal waste sludge 
incineration and cooling tower. Exposure to Nickel, Lead and Sulfur have been reported to 
significantly correlate with all-cause mortality in a study involving 6 US cities (Laden, Neas 
et al. 2000). Ni has also been reported to induce coronary vasoconstriction, decreased heart 
rate variability, increased incidence of arrhythmias, increased expression of cardiac 
cytokines IL-6 and TGF-β, and monocytic cell infiltration in animal models (Rubanyi and 
Kovach 1980). Lippman et al found that exposure of apoE-/- mice to PM2.5, containing Ni at 
an average concentration of 43 ng/m3 for 6h/day, 5d/wk for 6 months in Tuxedo, NY 
resulted in acute changes in heart rate, heart rate variability and enhanced atherosclerosis 
(Lippmann, Ito et al. 2006). It turns out that elevated concentrations of Ni in that area were 
in relation to Ni emitted from the International Nickel Company at Sudbury Ontario at a 
distance of more than 800 km away from NYC (Lippmann, Ito et al. 2006). Exposures to a 
similar PM2.5 mass but with different Ni contents that would determine different degrees of 
atherosclerosis would certainly substantiate the role of Ni metal in PM-mediated 
atherogenesis.  
7. Conclusions 
Several conclusions can be drawn about the cardiovascular effects of PM as follows: a) 
Short and long-term exposure to PM associates with various cardiovascular endpoints, 
especially of ischemic nature, likely in a causal manner, b) PM-induction of systemic 
prooxidative and proinflammatory effects appears to be key in the development of 
atherosclerosis, c) Particle size and chemical composition are important determinants of 
PM cardiovascular toxicity, d) Thorough characterization of the sources of exposure may 
help to identify toxic components of air pollution. 
Dissecting the actual contribution of each source of emissions to the CV effects would 
involve a more comprehensive characterization of the type of emissions that would need to 
go beyond PM mass-based metrics and include qualitative analysis. No single source is 
likely to account for all PM-mediated cardiovascular events in a dense urban setting and 
instead, various sources may contribute in different degrees in different locations. Therefore, 
to better assess the contribution of each source of emission to cardiovascular events, 
consideration should be given to the type of emission source, composition of the PM 
derived from the source of emissions and the proximity of the emission source to contact, 
among other factors. 
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